US20060122100A1 - Melanin extinguisher - Google Patents
Melanin extinguisher Download PDFInfo
- Publication number
- US20060122100A1 US20060122100A1 US10/527,179 US52717903A US2006122100A1 US 20060122100 A1 US20060122100 A1 US 20060122100A1 US 52717903 A US52717903 A US 52717903A US 2006122100 A1 US2006122100 A1 US 2006122100A1
- Authority
- US
- United States
- Prior art keywords
- metal chelate
- dimercaptooctanoyl
- acid
- compound
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 0 *C(=O)CCCCC1CCSCS1 Chemical compound *C(=O)CCCCC1CCSCS1 0.000 description 10
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
- C07K5/06113—Asp- or Asn-amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/315—Zinc compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D233/26—Radicals substituted by carbon atoms having three bonds to hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/02—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/51—Chelating agents
Definitions
- ⁇ -amino acid examples include 6-aminohexanoic acid.
- amino acids anthranilic acid, aminoethanesulfonic acid, methionine, histidine, lysine, phenylalanine, ⁇ -amino-L-butyric acid and 6-aminohexanoic acid are preferred.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/327,475 US8048911B2 (en) | 2002-09-13 | 2008-12-03 | Melanin eliminator preparation |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002-307643 | 2002-09-13 | ||
JP2002307643 | 2002-09-13 | ||
PCT/JP2003/011676 WO2004024139A1 (ja) | 2002-09-13 | 2003-09-11 | メラニン消去剤 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2003/011676 A-371-Of-International WO2004024139A1 (ja) | 2002-09-13 | 2003-09-11 | メラニン消去剤 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/327,475 Division US8048911B2 (en) | 2002-09-13 | 2008-12-03 | Melanin eliminator preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
US20060122100A1 true US20060122100A1 (en) | 2006-06-08 |
Family
ID=31987235
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/527,179 Abandoned US20060122100A1 (en) | 2002-09-13 | 2003-09-11 | Melanin extinguisher |
US12/327,475 Expired - Lifetime US8048911B2 (en) | 2002-09-13 | 2008-12-03 | Melanin eliminator preparation |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/327,475 Expired - Lifetime US8048911B2 (en) | 2002-09-13 | 2008-12-03 | Melanin eliminator preparation |
Country Status (7)
Country | Link |
---|---|
US (2) | US20060122100A1 (ja) |
EP (1) | EP1547590A4 (ja) |
JP (1) | JP4572115B2 (ja) |
KR (2) | KR100973450B1 (ja) |
CN (1) | CN100367949C (ja) |
AU (1) | AU2003264412A1 (ja) |
WO (1) | WO2004024139A1 (ja) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8647612B2 (en) * | 2008-03-05 | 2014-02-11 | Encore Health, Llc | Dithiol compounds, derivatives, and treatment of presbyopia |
US7914815B2 (en) | 2000-08-16 | 2011-03-29 | Encore Health, Llc | Method for delivery of pharmaceuticals for treating or preventing presbyopia |
US7935332B2 (en) * | 2000-08-16 | 2011-05-03 | Encore Health, Llc | Presbyopia treatment by lens alteration |
US8697109B2 (en) * | 2000-08-16 | 2014-04-15 | Encore Health, Llc | Caged mercaptan and seleno-mercaptan compounds and methods of using them |
JP2008174453A (ja) * | 2005-04-28 | 2008-07-31 | Iwaki Kk | 頭皮脱毛治療剤 |
KR100622286B1 (ko) * | 2005-10-06 | 2006-09-14 | 주식회사 바이오랜드 | 5-하이드록시트립토판을 함유하는 피부 미백 조성물 |
JP2007254423A (ja) * | 2006-03-24 | 2007-10-04 | Dhc Co | シート状パック材及びシート状パック材の品質保持方法 |
WO2008067403A2 (en) * | 2006-11-28 | 2008-06-05 | Encore Health Llc | Presbyopia treatment by lens alteration |
WO2009111635A2 (en) | 2008-03-05 | 2009-09-11 | Encore Health, Llc | Dithiol compounds, derivatives, and uses therefor |
US9044439B2 (en) * | 2008-03-05 | 2015-06-02 | Encore Health, Llc | Low dose lipoic and pharmaceutical compositions and methods |
US20110257130A1 (en) * | 2008-10-17 | 2011-10-20 | Desikan Rajagopal | Compositions and Methods for Treatment of Renin-Angiotensin Aldosterone System (RAAS)- Related Disorders |
CN101786975B (zh) * | 2009-01-22 | 2013-11-13 | 杭州民生药业有限公司 | 硫辛酰胺系列衍生物、制备方法及所述衍生物的制药用途 |
EP4082542A1 (en) | 2009-06-15 | 2022-11-02 | Encore Health, LLC | Dithiol compounds, derivatives, and uses therefor |
PT2821405E (pt) | 2009-06-15 | 2016-06-14 | Encore Health Llc | Ésteres de colina para tratar a presbiopia e a catarata |
ITFI20120170A1 (it) * | 2012-08-28 | 2014-03-01 | Consorzio Interuniversitario Nazion Ale Per La Sci | Nuovi composti ad azione anti-allodinica ed anti-iperalgesica. |
CA2895029A1 (en) * | 2012-12-19 | 2014-06-26 | Robert Shorr | Metal complexes of lipoic acid derivatives |
WO2015106200A2 (en) | 2014-01-10 | 2015-07-16 | Cornell University | Dipeptides as inhibitors of human immunoproteasomes |
US20160362402A1 (en) | 2014-02-27 | 2016-12-15 | Consorzio Interuniversitario Nazionale Per La Scienza E Tecnologia Dei Materiali | Novel compounds having anti-allodynic and antihyperalgesic activity |
CA2941518A1 (en) | 2014-03-03 | 2015-09-11 | Encore Vision, Inc. | Lipoic acid choline ester compositions and methods of use |
WO2016028571A2 (en) | 2014-08-18 | 2016-02-25 | Cornell University | Dipeptidomimetics as inhibitors of human immunoproteasomes |
WO2016170990A1 (ja) * | 2015-04-18 | 2016-10-27 | ジェイオーコスメティックス株式会社 | チロシナーゼ活性阻害剤および皮膚外用剤 |
EP3362754B1 (en) | 2015-10-15 | 2021-12-22 | Cornell University | Proteasome inhibitors and uses thereof |
EP3694605A4 (en) | 2017-10-11 | 2021-10-27 | Cornell University | PEPTIDOMIMETIC PROTEASOME INHIBITORS |
JP7328480B2 (ja) * | 2018-09-14 | 2023-08-17 | 株式会社applause Pharma | チロシン-チロシナーゼ反応阻害剤 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5830994A (en) * | 1993-09-22 | 1998-11-03 | Institut Europeen De Biologie Cellulaire | Peptide derivatives of alpha-MSH and their application |
US20040092586A1 (en) * | 2001-03-19 | 2004-05-13 | Kazumi Ogata | Novel a-lipoic acid derivative and use thereof |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2002103A (en) * | 1932-06-30 | 1935-05-21 | Standard Oil Co | Pipe anchor |
GB935962A (en) | 1960-06-17 | 1963-09-04 | Fujisawa Pharmaceutical Co | Improvements in or relating to the production of 6.8-dithiooctanamides |
JPS56120611A (en) * | 1980-02-26 | 1981-09-22 | Pola Chem Ind Inc | Beautifying cosmetic |
JPS6011494A (ja) * | 1983-06-29 | 1985-01-21 | Sumitomo Chem Co Ltd | 有機ゲルマニウム化合物 |
JPS638316A (ja) * | 1986-06-28 | 1988-01-14 | Sansho Seiyaku Kk | 外用剤 |
US6365623B1 (en) * | 1997-11-17 | 2002-04-02 | Nicholas V. Perricone | Treatment of acne using lipoic acid |
AU6001299A (en) * | 1998-10-02 | 2000-04-26 | Sankyo Company Limited | Dithiol derivatives |
JP2000169371A (ja) | 1998-10-02 | 2000-06-20 | Sankyo Co Ltd | ジチオラン誘導体を含有する医薬 |
JP2000169443A (ja) * | 1998-10-02 | 2000-06-20 | Sankyo Co Ltd | ジチオ―ル誘導体 |
IL142824A0 (en) * | 1998-10-26 | 2002-03-10 | Univ New York State Res Found | Lipoic acid derivatives and their use in treatment of disease |
WO2000032235A1 (de) * | 1998-11-26 | 2000-06-08 | Pentapharm Ag | Transportsystemkonjugate |
US6288106B1 (en) | 1999-05-25 | 2001-09-11 | Chronorx, Llc | Processes for the synthesis and use of various α-lipoic acid complexes |
-
2003
- 2003-09-11 CN CNB03821816XA patent/CN100367949C/zh not_active Expired - Lifetime
- 2003-09-11 KR KR1020057004316A patent/KR100973450B1/ko active IP Right Grant
- 2003-09-11 JP JP2004535955A patent/JP4572115B2/ja not_active Expired - Lifetime
- 2003-09-11 WO PCT/JP2003/011676 patent/WO2004024139A1/ja active Application Filing
- 2003-09-11 AU AU2003264412A patent/AU2003264412A1/en not_active Abandoned
- 2003-09-11 EP EP03795415A patent/EP1547590A4/en not_active Withdrawn
- 2003-09-11 KR KR1020107003305A patent/KR100973451B1/ko active IP Right Grant
- 2003-09-11 US US10/527,179 patent/US20060122100A1/en not_active Abandoned
-
2008
- 2008-12-03 US US12/327,475 patent/US8048911B2/en not_active Expired - Lifetime
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5830994A (en) * | 1993-09-22 | 1998-11-03 | Institut Europeen De Biologie Cellulaire | Peptide derivatives of alpha-MSH and their application |
US20040092586A1 (en) * | 2001-03-19 | 2004-05-13 | Kazumi Ogata | Novel a-lipoic acid derivative and use thereof |
Also Published As
Publication number | Publication date |
---|---|
KR100973450B1 (ko) | 2010-08-02 |
CN100367949C (zh) | 2008-02-13 |
KR20100023057A (ko) | 2010-03-03 |
US8048911B2 (en) | 2011-11-01 |
KR100973451B1 (ko) | 2010-08-02 |
WO2004024139A1 (ja) | 2004-03-25 |
JPWO2004024139A1 (ja) | 2006-01-05 |
EP1547590A1 (en) | 2005-06-29 |
JP4572115B2 (ja) | 2010-10-27 |
KR20050047114A (ko) | 2005-05-19 |
CN1681490A (zh) | 2005-10-12 |
US20090093541A1 (en) | 2009-04-09 |
AU2003264412A1 (en) | 2004-04-30 |
EP1547590A4 (en) | 2008-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8048911B2 (en) | Melanin eliminator preparation | |
JP4072062B2 (ja) | 新規α−リポ酸誘導体およびその用途 | |
JP2008174453A (ja) | 頭皮脱毛治療剤 | |
EP0082088A1 (fr) | Nouveaux dérivés d'aminoacides, et leur application thérapeutique | |
JPS58113157A (ja) | アンジオテンシン変換酵素阻害剤 | |
AU733420B2 (en) | Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors | |
US4931471A (en) | Amides of paramethoxycinnamic and utilization thereof as solar filters | |
JPH0322993A (ja) | 水溶性l−チロシン誘導体およびl−チロシン誘導体の製造方法 | |
US5298647A (en) | Aromatic compounds of amide structure derived from aminobenzoic acids, hydroxy-benzoic acids, cinnamic acids, urocanic acids and benzimidazoles, absorbing UVB and/or UVA | |
JP3457687B2 (ja) | 白内障治療用薬剤 | |
JP2003286168A (ja) | α−リポイルアミノ酸を含有する皮膚外用剤 | |
JP2011195516A (ja) | 制がん剤 | |
JP4259813B2 (ja) | α−リポイルアミノ酸の安定化法および安定化されたα−リポイルアミノ酸を含有する水性液剤 | |
US4801579A (en) | Novel cystine compounds, their preparation and use | |
US8003614B2 (en) | Dipeptides incorporating selenoamino acids with enhanced bioavailability—synthesis, pharmaceutical and cosmeceutical applications thereof | |
US4980343A (en) | Aminooxodihydroisoindoloquinazoline carcinostatic agents | |
CN102964283B (zh) | 4-氨基硫脲缩甲醛基苯甲(氨基酸)酰胺化合物及其应用 | |
FR2950890A1 (fr) | Procede de synthese de la 2-thiohistidine et analogues | |
WO1995000495A1 (fr) | Derives d'aminopyri(mi)dines associes a des acides amines, et leurs activites pharmacologiques | |
JPH0834779A (ja) | トコフェロール誘導体 | |
JPS61249997A (ja) | グルタチオンアルキルエステルおよびその用途 | |
GB2114561A (en) | Anti-hypertensive agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: OGA RESEARCH, INCORPORATED, JAPAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:OGATA, KAZUMI;REEL/FRAME:017210/0361 Effective date: 20050228 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |